DAPASUG-5
MRP: 950
Packaging: 10x10
Pack Type: tablet
Composition:
Dapagliflozin 5mg
Indication:
Type 2 Diabetes
Description:
Dapagliflozin 5 mg** is an oral antidiabetic medicine belonging to the class of SGLT2 inhibitors (Sodium-Glucose Co-Transporter-2 inhibitors). It lowers blood sugar levels by blocking the reabsorption of glucose in the kidneys, promoting its excretion through urine.
This 5 mg strength is typically used as a starting dose or for dose adjustment in patients with Type 2 Diabetes Mellitus, especially those at risk of adverse effects from higher doses or those with certain kidney or heart conditions. Dapagliflozin also offers benefits beyond glucose control, such as weight loss, blood pressure reduction, and cardio-renal protection.
Tags:
- Helps reduce blood glucose levels effectively
- Supports weight reduction in diabetic patients
- Aids in lowering blood pressure
- Reduces risk of heart failure and kidney disease progression
- Can be combined with other antidiabetics for enhanced effect
Usage Information
Dosage
Recommended Dose: One 5 mg tablet once daily Can be taken with or without food Continue taking as prescribed even if you feel well Do not double the dose if missed—take the next dose as scheduled
Side Effects
Frequent urination Genital fungal infections Urinary tract infections Thirst or dehydration Rare: Diabetic ketoacidosis, especially in insulin users
Contraindications
Hypersensitivity to Dapagliflozin or any ingredient Type 1 Diabetes Mellitus Diabetic ketoacidosis history Severe kidney dysfunction or end-stage renal disease Not recommended during pregnancy or lactation without medical supervision
Availability
Dapagliflozin 5 mg tablet SGLT2 inhibitor for diabetes Oral diabetes medicine Blood sugar control medication Dapagliflozin for heart and kidney health Type 2 Diabetes drug Low dose Dapagliflozin Weight loss with Dapagliflozin Cardiovascular support diabetes Dapagliflozin for CKD